Milind Javle, MD, The University of Texas MD Anderson Cancer Center

Articles

Liver-Directed Treatment Strategies in Biliary Tract Cancers

March 1st 2023

A comprehensive review of liver-directed therapies available to aid in the management of biliary tract cancers.

Biliary Tract Cancers: Surgical and Perioperative Treatment Strategies

March 1st 2023

Moving on to identify specific treatment modalities, panelists discuss the surgical and perioperative strategies used to manage biliary tract cancers.

Advent of Molecular Testing in Biliary Tract Cancers

February 22nd 2023

Key opinion leaders review the advent of molecular testing in biliary tract cancers and consider its impact on informing treatment decisionmaking.

Optimizing the Staging of Biliary Tract Cancers

February 22nd 2023

Focused conversation on the optimal workup and staging of biliary tract cancers within the current paradigm.

Clinical Scenario: Diagnostic Strategies to Identify Biliary Tract Cancers

February 15th 2023

Centering focus on a patient scenario, panelists break down mainstay diagnostic strategies used to identify biliary tract cancers.

Overview on Biliary Tract Cancers and Their Rising Incidence

February 15th 2023

Expert panelists open their discussion on biliary tract cancers by identifying various subsets and noting the growing incidence of these diseases.

Advanced Biliary Tract Cancers: Novel Biomarker Strategies

November 9th 2022

Closing out their discussion on the management of biliary tract cancers, experts share excitement for future evolutions in the treatment landscape.

Novel Agents Being Explored in Advanced Biliary Tract Cancers

November 9th 2022

Expert panelists provide comprehensive insight on novel targeted agents being investigated in advanced biliary tract cancers.

Sequencing Therapy in Patients With Advanced Biliary Tract Cancers

November 2nd 2022

In the context of advanced biliary tract cancers, panelists reflect on the optimal sequencing of agents throughout multiple lines of therapy.

Advanced Biliary Tract Cancers: Managing Immunotherapy-Related Adverse Events

November 2nd 2022

Expert perspectives on the toxicity profile of immunotherapy agents and how they can be managed in patients being treated for advanced biliary tract cancers.

Advanced BTC: Informing Use of IO Therapy in Specific Patient Populations

October 26th 2022

Shared insight on efforts to identify patient subgroups that may benefit more from immunotherapy in the setting of advanced biliary tract cancers.

TOPAZ-1: Durvalumab + Doublet Chemotherapy in Advanced Biliary Tract Cancers

October 26th 2022

Centering their conversation on the TOPAZ-1 clinical trial, expert panelists review the use of IO + chemotherapy in advanced biliary tract cancers.

Advanced Biliary Tract Cancers: First- and Second-Line Chemotherapy

October 19th 2022

Focused discussion on chemotherapy treatment options commonplace in patients with advanced or metastatic biliary tract cancers.

An Overview of Systemic Therapy for Advanced Biliary Tract Cancers

October 19th 2022

Shifting their focus to the advanced disease setting, panelists provide a comprehensive overview on systemic treatment modalities used in biliary tract cancers.

Understanding the Role of Adjuvant Therapy in Biliary Tract Cancers

October 12th 2022

Experts provide brief perspective on the use of adjuvant treatment approaches for patients with biliary tract cancers.

What is the Role of Transplant in Early-Stage Biliary Tract Cancers?

October 12th 2022

Before closing out their review of early-stage biliary tract cancer treatment options, panelists consider the role of transplant in the setting.

Treatment Options for Early-Stage Biliary Tract Cancers

October 5th 2022

Centering discussion on early-stage biliary tract cancers, expert panelists consider the respective roles of surgery and embolization strategies in this setting.

Guidelines for Molecular Testing in Biliary Tract Cancers

October 5th 2022

Panelists share their perspectives on molecular testing guidelines for patients diagnosed with biliary tract cancers.

Biliary Tract Cancers: Staging and Clinicopathologic Features

September 28th 2022

Comprehensive insight on staging biliary tract cancers followed by an overview of molecular testing and targetable clinicopathologic features.

Challenges in Diagnosing Biliary Tract Cancers

September 28th 2022

Expert perspectives on the presentation of biliary tract cancers with specific insight to the challenges inherent in reaching a timely diagnosis.